The Tests Your Doctor Probably Didn't Order — and Why Cnvrg Asks for Them

A standard blood panel — the one your doctor orders at your annual physical — was designed with a specific goal: catch disease early. It does that reasonably well. What it was not designed to do is tell a healthy person how their biology is actually aging, or flag the slow, low-grade processes that precede disease by years or decades.

Cnvrg asks for a different set of markers. Some overlap with what a standard panel includes. Several do not. Here is why each non-standard marker is on the list, and what it tells you that routine bloodwork misses.

hs-CRP — High-Sensitivity C-Reactive Protein

A standard CRP test is designed to detect acute inflammation — the kind that comes with an active infection or injury. It is measured in units of mg/L and flagged when values exceed 10 or 20. High-sensitivity CRP measures the same protein, but at much lower concentrations — the range relevant to chronic, low-grade inflammation. The clinical thresholds are 1.0 mg/L (low risk), 1.0 to 3.0 mg/L (intermediate), and above 3.0 mg/L (high risk).

This distinction matters because chronic low-grade inflammation — not acute infection — is the mechanism that drives cardiovascular disease, accelerated biological aging, and insulin resistance. The standard CRP test cannot see it. The hs-CRP test can.

For Cnvrg specifically, hs-CRP is one of the nine markers in the PhenoAge biological age calculation and the primary blood-side signal in cross-panel rules connecting oral health to systemic inflammation. If your hs-CRP is elevated, Cnvrg can often identify which upstream input — oral bacteria, sleep disruption, autonomic stress — is most likely driving it.

Ask for it as: "high-sensitivity CRP" or "hs-CRP." Standard CRP is not the same test.

Lp(a) — Lipoprotein little a

Lp(a) is a lipoprotein particle that carries LDL cholesterol but behaves differently from standard LDL in ways that matter clinically. It is genetically determined — roughly 80 percent of your Lp(a) level is set by your DNA and does not respond meaningfully to diet or most medications. Elevated Lp(a) is found in approximately 20 percent of the population and is associated with significantly elevated cardiovascular risk independent of LDL, HDL, and triglycerides.

The reason it rarely appears on a standard lipid panel is primarily historical — it was not part of the original Framingham risk model, and most cardiovascular risk calculators still do not include it. This is changing: the 2023 ACC/AHA guidelines now recommend Lp(a) testing at least once in every adult's life for risk stratification.

Lp(a) is not modifiable through lifestyle in the way LDL is, which makes it more of a fixed risk factor than an intervention target. What it does is change the context of your other markers — an LDL of 130 mg/L means something different if your Lp(a) is 15 versus 120. Cnvrg includes it because knowing your fixed genetic cardiovascular risk changes how aggressively you should manage the modifiable factors.

Ask for it as: "Lp(a)" or "lipoprotein a." It is not included in a standard lipid panel.

RDW — Red Cell Distribution Width

RDW appears on a complete blood count but is almost never discussed in a routine appointment. It measures the variation in size of your red blood cells — a high RDW means your red cells are more unequal in size. It is traditionally used to help distinguish between types of anemia.

What the longevity research has since found is that RDW is also a sensitive marker of systemic stress and biological aging. It is one of the nine markers in the Levine PhenoAge formula. Elevated RDW — even within the conventional normal range — is associated with higher all-cause mortality in multiple large prospective studies, independent of anemia status. The mechanistic interpretation is that elevated RDW reflects inefficient or stressed red cell production, which in turn reflects nutritional deficiency (B12, folate, iron), chronic inflammation, or oxidative stress.

Your doctor almost certainly already ordered RDW as part of your CBC. It just was not discussed. Cnvrg uses it.

MPV — Mean Platelet Volume

MPV measures the average size of your platelets. Larger platelets are more metabolically active and more prone to aggregation — they clot more readily. Elevated MPV has been associated with cardiovascular risk, particularly in the context of existing inflammation, and is inversely related to platelet count (when platelet count falls, MPV tends to rise as the bone marrow compensates by releasing larger, younger platelets).

Like RDW, MPV is already on most CBC reports but rarely discussed. Cnvrg uses it as part of the cellular health picture, particularly in cross-panel rules connecting oral infection to platelet activation via the same bacteremia pathway that drives CRP elevation.

Ask for it as: it is almost always included in a standard CBC differential. You likely already have it.

HbA1c — Glycated Hemoglobin

HbA1c appears on some standard panels but not all, and is often ordered only when diabetes is already suspected. It measures the percentage of hemoglobin that has been glycated — bound to glucose — over the preceding two to three months, making it a far more stable measure of average blood sugar than a fasting glucose test.

The reason Cnvrg includes it alongside fasting glucose is the window it provides into metabolic trajectory. A fasting glucose of 98 mg/dL can look normal while HbA1c is already trending toward 5.7 percent — the pre-diabetes threshold. The two together tell a more complete story than either alone. In the Cnvrg cross-panel rules, HbA1c is the blood-side input in metabolic convergence rules that also involve oral DNRA bacteria and wearable autonomic signals.

Ask for it as: "HbA1c" or "hemoglobin A1c." Some panels include it; many do not unless diabetes is a stated concern.

Vitamin D (25-OH)

Vitamin D is technically a hormone precursor, and its receptors are found on nearly every cell type in the body. Deficiency — defined as below 20 ng/mL, with insufficiency below 30 ng/mL — is common, affecting an estimated 40 percent of adults in the United States. Standard panels often do not include it unless specifically requested.

Cnvrg includes it because vitamin D has documented roles in immune regulation, oral tissue integrity, and sleep architecture. Rules 16A and 16B in the cross-panel engine connect low vitamin D to both reduced oral immune defense and poor deep sleep — two pathways that are independent of the more commonly discussed bone health applications. Vitamin D is also one of the more actionable markers: supplementation and sun exposure are effective interventions with clear dose-response data.

Ask for it as: "25-OH vitamin D" or "25-hydroxyvitamin D." The 1,25 form is a different test and is not what Cnvrg uses.

The Underlying Principle

None of these markers are exotic. They are all available through standard clinical laboratories, most cost less than standard tests, and several are already on your existing CBC report unread. The difference is that they were selected not to screen for disease in a sick population but to characterize biological aging and cross-system inflammation in people who feel fine. That is a different purpose, and it requires a different panel.

When Cnvrg asks you to add hs-CRP or Lp(a) to your next blood draw, it is not upselling a test. It is closing the gap between what your doctor ordered for disease screening and what you need to see how your biology is actually aging.

Sources

Ridker PM. NEJM. 2002. PMID: 11794149. Nordestgaard BG et al. Eur Heart J. 2023. DOI: 10.1093/eurheartj/ehad071. Levine ME et al. Aging (Albany NY). 2018. PMID: 29676998. Gasparyan AY et al. Inflamm Allergy Drug Targets. 2011. PMID: 21261585.